Stevanato Group S.p.A (STVN) Cash from Financing Activities (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Cash from Financing Activities of -$29.2 million for Q1 2026, up 22.49% year-over-year from -$23.8 million in Q1 2025, and down 245.6% quarter-over-quarter from $20.0 million in Q4 2025.
Stevanato Group S.p.A (STVN) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Cash from Financing Activities for 7 consecutive years, with -$29.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 22.49% year-over-year to -$29.2 million; the TTM figure through Mar 2026 stood at $37.5 million (up 2306.28% YoY), while the FY2025 annual figure was $25.7 million, down 86.86% from the prior year.
- Cash from Financing Activities fell to -$29.2 million in Q1 2026 per STVN's latest filing, from $20.0 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $159.5 million in Q1 2024 and bottomed at -$64.0 million in Q2 2024.
- Historically, Cash from Financing Activities has averaged $19.0 million across 5 years, with a median of $8.6 million in 2023.
- Annual changes were most pronounced in 2024 — Cash from Financing Activities surged 1758.04% — and 2025, when it sank 123.57%.
- Stevanato Group S.p.A's Cash from Financing Activities stood at -$19.0 million in 2022, then soared by 597.24% to $94.4 million in 2023, then fell by 24.92% to $70.8 million in 2024, then tumbled by 71.74% to $20.0 million in 2025, then tumbled by 245.6% to -$29.2 million in 2026.
- Business Quant data shows STVN's Cash from Financing Activities at -$29.2 million in Q1 2026, $20.0 million in Q4 2025, and $22.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | -2.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.17 Mn |
| Jun 30, 2026 | -2.17 Mn |
| Mar 31, 2026 | -29.15 Mn |
| Mar 31, 2026 | -29.15 Mn |
| Dec 31, 2025 | 20.02 Mn |
| Dec 31, 2025 | 20.02 Mn |
| Sep 30, 2025 | 22.68 Mn |
| Sep 30, 2025 | 22.68 Mn |
| Jun 30, 2025 | 24.00 Mn |
| Jun 30, 2025 | 24.00 Mn |
| Mar 31, 2025 | -37.61 Mn |
| Mar 31, 2025 | -37.61 Mn |
| Dec 31, 2024 | 70.85 Mn |
| Dec 31, 2024 | 70.85 Mn |
| Sep 30, 2024 | 32.29 Mn |
| Sep 30, 2024 | 32.29 Mn |
| Jun 30, 2024 | -63.97 Mn |
| Jun 30, 2024 | -63.97 Mn |
| Mar 31, 2024 | 159.55 Mn |
| Mar 31, 2024 | 159.55 Mn |